Your browser doesn't support javascript.
loading
A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia.
Oda, Shannon K; Daman, Andrew W; Garcia, Nicolas M; Wagener, Felecia; Schmitt, Thomas M; Tan, Xiaoxia; Chapuis, Aude G; Greenberg, Philip D.
Afiliação
  • Oda SK; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA; and.
  • Daman AW; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA; and.
  • Garcia NM; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA; and.
  • Wagener F; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA; and.
  • Schmitt TM; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA; and.
  • Tan X; Department of Immunology, University of Washington, Seattle, WA.
  • Chapuis AG; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA; and.
  • Greenberg PD; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA; and.
Blood ; 130(22): 2410-2419, 2017 11 30.
Article em En | MEDLINE | ID: mdl-29042364
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteínas de Membrana / Linfócitos T / Leucemia / Imunoterapia Adotiva / Antígenos CD28 / Receptores de Superfície Celular / Antígenos de Superfície Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteínas de Membrana / Linfócitos T / Leucemia / Imunoterapia Adotiva / Antígenos CD28 / Receptores de Superfície Celular / Antígenos de Superfície Idioma: En Ano de publicação: 2017 Tipo de documento: Article